GemVax&KAELLtd Balance Sheet Health
Financial Health criteria checks 5/6
GemVax&KAELLtd has a total shareholder equity of ₩81.3B and total debt of ₩36.3B, which brings its debt-to-equity ratio to 44.7%. Its total assets and total liabilities are ₩138.8B and ₩57.5B respectively.
Key information
44.7%
Debt to equity ratio
₩36.33b
Debt
Interest coverage ratio | n/a |
Cash | ₩18.61b |
Equity | ₩81.26b |
Total liabilities | ₩57.50b |
Total assets | ₩138.76b |
Recent financial health updates
Recent updates
Some Confidence Is Lacking In GemVax&KAEL Co.,Ltd. (KOSDAQ:082270) As Shares Slide 28%
Nov 04GemVax&KAEL Co.,Ltd.'s (KOSDAQ:082270) 30% Share Price Surge Not Quite Adding Up
Sep 19Risks To Shareholder Returns Are Elevated At These Prices For GemVax&KAEL Co.,Ltd. (KOSDAQ:082270)
Jul 05GemVax&KAELLtd's (KOSDAQ:082270) Earnings Are Weaker Than They Seem
Apr 03Is GemVax&KAELLtd (KOSDAQ:082270) A Risky Investment?
Feb 17Investors Who Bought GemVax&KAELLtd (KOSDAQ:082270) Shares Three Years Ago Are Now Up 52%
Dec 26Financial Position Analysis
Short Term Liabilities: A082270's short term assets (₩33.4B) exceed its short term liabilities (₩30.8B).
Long Term Liabilities: A082270's short term assets (₩33.4B) exceed its long term liabilities (₩26.7B).
Debt to Equity History and Analysis
Debt Level: A082270's net debt to equity ratio (21.8%) is considered satisfactory.
Reducing Debt: A082270's debt to equity ratio has increased from 27.4% to 44.7% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: A082270 has sufficient cash runway for 9 months based on last reported free cash flow, but has since raised additional capital.
Forecast Cash Runway: A082270 is forecast to have sufficient cash runway for 5 months based on free cash flow estimates, but has since raised additional capital.